Kyungdong Pharmaceutical Rises 5.16% Amid COVID-19 (Dexamethasone) Theme Uptrend

On the 6th, the COVID-19 (Dexamethasone) theme rose 3.81% compared to the previous day, showing a strong performance, while Kyungdong Pharmaceutical, which is attracting attention as a related stock, surged 5.16% compared to the previous day. Kyungdong Pharmaceutical is known as a specialty pharmaceutical company.

[Graph] Major stock price changes in the COVID-19 (Dexamethasone) theme

According to preliminary data compiled at 14:36, foreigners are net selling 3,000 shares of Kyungdong Pharmaceutical, while institutions are net buying 3,000 shares.

[Table] Net trading volume by foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Kyungdong Pharmaceutical ranks 5th out of 15 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Kyungdong Pharmaceutical having relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.